Indoco Remedies (INDOCO.NS) Stock Price

Indoco Remedies Price

NSE·CLOSED
219.49INR-1.02 (-0.46 %)
Market closed

Over the last 19 years Indoco Remedies grew revenue by 10.6% annually, reaching 16.65 B INR. Earnings per share have grown at 6.9% per year over the last 18 years. For Indoco Remedies, the net margin of -4.4% is down versus 7.5% a few years ago. At today's price the dividend yield works out to roughly 0.09%. The consensus 12-month price target for Indoco Remedies is 261.63 INR, about 19.2% above where the stock trades today. Of 9 analysts, 1 rate the stock a buy — an overall Sell consensus. The stock trades about 34% above its 52-week low.

Indoco Remedies stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Indoco Remedies over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Indoco Remedies stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Indoco Remedies's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Indoco Remedies Stock Price History
DateIndoco Remedies Price
7/31/2026219.49 INR
7/30/2026220.51 INR
7/28/2026245.00 INR
7/24/2026243.42 INR
7/23/2026238.15 INR
7/22/2026233.20 INR
7/20/2026244.55 INR
7/17/2026247.45 INR
7/15/2026249.57 INR
7/14/2026248.53 INR
7/13/2026259.02 INR
7/10/2026260.23 INR
7/9/2026255.09 INR
7/8/2026248.14 INR
7/7/2026237.07 INR
7/6/2026235.64 INR
7/3/2026243.79 INR
7/2/2026244.02 INR
7/1/2026236.68 INR
6/30/2026239.22 INR
6/29/2026234.06 INR
6/25/2026231.60 INR
6/24/2026237.20 INR
6/23/2026236.52 INR
6/22/2026236.42 INR
6/19/2026234.99 INR
6/18/2026232.09 INR
6/17/2026231.23 INR
6/16/2026232.97 INR
6/15/2026242.07 INR
6/12/2026248.80 INR
6/11/2026243.00 INR
6/10/2026204.96 INR
6/9/2026205.86 INR
6/8/2026199.53 INR
6/5/2026206.84 INR
6/4/2026213.28 INR
6/3/2026207.43 INR
6/2/2026207.25 INR
6/1/2026210.19 INR
5/29/2026209.66 INR
5/28/2026204.00 INR
5/27/2026204.00 INR
5/26/2026193.13 INR
5/25/2026195.74 INR
5/22/2026199.08 INR
5/21/2026204.29 INR
5/20/2026211.72 INR
5/19/2026213.77 INR
5/18/2026215.26 INR
5/15/2026224.90 INR
5/14/2026225.53 INR
5/13/2026225.97 INR
5/12/2026217.80 INR
5/11/2026218.92 INR
5/8/2026227.91 INR
5/7/2026250.65 INR
5/6/2026228.68 INR
5/5/2026215.26 INR
5/4/2026211.86 INR
5/1/2026209.49 INR
4/30/2026209.49 INR
4/29/2026209.51 INR
4/28/2026211.45 INR
4/27/2026208.99 INR
4/24/2026206.34 INR
4/23/2026213.78 INR
4/22/2026214.18 INR
4/21/2026213.20 INR
4/20/2026215.63 INR
4/17/2026219.55 INR
4/16/2026217.07 INR
4/15/2026218.07 INR
4/13/2026211.60 INR
4/10/2026202.41 INR
4/9/2026201.42 INR
4/8/2026198.22 INR
4/7/2026192.88 INR
4/6/2026189.35 INR
4/2/2026187.28 INR
4/1/2026187.08 INR
3/30/2026164.00 INR
3/27/2026173.46 INR
3/25/2026185.90 INR
3/24/2026184.51 INR
3/23/2026182.93 INR
3/20/2026192.20 INR
3/19/2026188.81 INR
3/18/2026193.59 INR
3/17/2026192.98 INR
3/16/2026189.11 INR
3/13/2026196.28 INR
3/12/2026200.01 INR
3/11/2026194.43 INR
3/10/2026196.54 INR
3/9/2026194.44 INR
3/6/2026198.36 INR
3/5/2026197.55 INR
3/4/2026196.17 INR
3/2/2026200.71 INR
2/27/2026202.28 INR
2/26/2026204.23 INR
2/25/2026203.05 INR
2/24/2026203.11 INR
2/23/2026199.81 INR
2/20/2026198.26 INR
2/19/2026200.08 INR
2/18/2026202.52 INR
2/17/2026202.32 INR
2/16/2026201.56 INR
2/13/2026202.42 INR
2/12/2026204.78 INR
2/11/2026204.93 INR
2/10/2026210.40 INR
2/9/2026205.01 INR
2/6/2026212.76 INR
2/5/2026222.02 INR
2/4/2026225.60 INR
2/3/2026234.54 INR
2/2/2026211.94 INR
1/30/2026217.51 INR
1/29/2026212.92 INR
1/28/2026216.70 INR
1/27/2026218.79 INR
1/23/2026210.36 INR
1/22/2026215.71 INR
1/21/2026206.95 INR
1/20/2026208.42 INR
1/19/2026213.73 INR
1/16/2026219.20 INR
1/15/2026210.96 INR
1/14/2026210.96 INR
1/13/2026216.22 INR
1/12/2026215.18 INR
1/9/2026217.74 INR
1/8/2026221.52 INR
1/7/2026225.02 INR
1/6/2026229.03 INR
1/5/2026227.61 INR
1/2/2026226.65 INR
1/1/2026229.47 INR
12/31/2025234.60 INR
12/30/2025230.60 INR
12/29/2025225.90 INR
12/26/2025225.95 INR
12/24/2025234.65 INR
12/23/2025236.85 INR
12/22/2025237.55 INR
12/19/2025239.60 INR
12/18/2025237.80 INR
12/17/2025240.55 INR
12/16/2025244.85 INR
12/15/2025247.40 INR
12/12/2025242.55 INR
12/11/2025239.45 INR
12/10/2025236.90 INR
12/9/2025239.50 INR
12/8/2025252.50 INR
12/5/2025251.70 INR
12/4/2025252.25 INR
12/3/2025255.40 INR
12/2/2025261.65 INR
12/1/2025257.85 INR
11/28/2025256.15 INR
11/27/2025257.95 INR
11/26/2025261.30 INR
11/25/2025254.95 INR
11/24/2025252.80 INR
11/21/2025257.25 INR
11/20/2025252.05 INR
11/19/2025260.30 INR
11/18/2025268.05 INR
11/17/2025260.05 INR
11/14/2025262.90 INR
11/13/2025267.25 INR
11/12/2025268.05 INR
11/11/2025269.25 INR
11/10/2025265.55 INR
11/7/2025260.95 INR
11/6/2025264.45 INR
11/4/2025270.95 INR
11/3/2025274.85 INR
10/31/2025279.15 INR
10/30/2025280.55 INR
10/29/2025275.25 INR
10/28/2025273.20 INR
10/27/2025276.80 INR
10/24/2025281.35 INR
10/23/2025282.20 INR
10/21/2025287.80 INR
10/20/2025286.80 INR
10/17/2025285.20 INR
10/16/2025292.10 INR
10/15/2025286.05 INR
10/14/2025294.85 INR
10/13/2025296.85 INR
10/10/2025287.30 INR
10/9/2025290.80 INR
10/8/2025294.65 INR
10/7/2025291.00 INR
10/6/2025284.00 INR
10/3/2025290.60 INR
10/1/2025290.15 INR
9/30/2025291.95 INR
9/29/2025289.95 INR
9/26/2025285.80 INR
9/25/2025302.00 INR
9/24/2025302.45 INR
9/23/2025301.90 INR
9/22/2025298.70 INR
9/19/2025301.95 INR
9/18/2025301.75 INR
9/17/2025299.80 INR
9/16/2025304.70 INR
9/15/2025293.55 INR
9/12/2025299.05 INR
9/11/2025308.60 INR
9/10/2025276.85 INR
9/9/2025276.70 INR
9/8/2025277.00 INR
9/5/2025273.55 INR
9/4/2025273.10 INR
9/3/2025281.75 INR
9/2/2025275.70 INR
9/1/2025267.90 INR
8/29/2025266.60 INR
8/28/2025274.20 INR
8/26/2025277.25 INR
8/25/2025282.85 INR
8/22/2025279.55 INR
8/21/2025278.45 INR
8/20/2025283.10 INR
8/19/2025291.35 INR
8/18/2025293.40 INR
8/14/2025285.10 INR
8/13/2025293.70 INR
8/12/2025293.00 INR
8/11/2025284.30 INR
8/8/2025291.85 INR
8/7/2025284.05 INR
8/6/2025291.55 INR
8/5/2025299.25 INR
Access this data via the Eulerpool API
Get Free API Key

Indoco Remedies Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2021
12.42 B INR
1.51 B INR
930.00 M INR
Jan 1, 2022
15.41 B INR
2.51 B INR
1.55 B INR
Jan 1, 2023
16.69 B INR
2.17 B INR
1.42 B INR
Jan 1, 2024
18.17 B INR
1.53 B INR
984.60 M INR
Jan 1, 2025
16.65 B INR
-138.50 M INR
-737.37 M INR
Jan 1, 2026 (e)
17.59 B INR
1.40 B INR
-753.69 M INR
Jan 1, 2027 (e)
21.01 B INR
1.67 B INR
486.33 M INR
Jan 1, 2028 (e)
24.16 B INR
1.93 B INR
1.15 B INR

Indoco Remedies Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 4, 2026, 7:28 PM
 
REVENUEB INR
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB INR
EBITB INR
EBIT MARGIN%
NET INCOMEB INR
NET INCOME GROWTH%
DIV.INR
DIV. GROWTH%
SHARESM
20132014201520162017201820192020202120222023202420252026e2027e2028e
6.317.338.5710.0810.9710.459.6811.0712.4215.4116.6918.1716.6517.5921.0124.16
10.9016.1416.9817.638.80-4.70-7.3614.2712.1924.118.298.91-8.385.6419.4714.99
55.0959.6161.7462.3461.9362.5962.6765.6567.2266.1064.6464.8966.1366.1366.1366.13
3.484.375.296.286.796.546.077.278.3510.1810.7911.7911.0111.6313.9015.98
0.690.901.181.150.940.670.060.561.512.512.171.53-0.141.401.671.93
10.9412.2213.8211.398.526.450.585.0212.1916.2613.008.44-0.837.977.977.97
0.430.580.830.820.770.41-0.030.240.931.551.420.98-0.74-0.750.491.15
-7.7835.8342.76-1.09-5.86-46.56-107.04-931.03285.8966.45-8.14-30.80-174.902.17-164.54137.04
1.101.401.601.600.401.000.300.301.501.502.251.500.200.200.200.20
–27.2714.29–-75.00150.00-70.00–400.00–50.00-33.33-86.67–––
92.0092.0092.0092.0092.0092.0092.0092.0092.0092.0092.2692.2692.1992.1992.1992.19
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Indoco Remedies generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Indoco Remedies retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Indoco Remedies's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Indoco Remedies has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Indoco Remedies's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Indoco Remedies stock margins

The Indoco Remedies margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Indoco Remedies. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Indoco Remedies.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
67.22 %
12.19 %
7.49 %
Jan 1, 2022
66.10 %
16.26 %
10.05 %
Jan 1, 2023
64.65 %
13.00 %
8.53 %
Jan 1, 2024
64.89 %
8.44 %
5.42 %
Jan 1, 2025
66.13 %
-0.83 %
-4.43 %
Jan 1, 2026 (e)
66.13 %
7.97 %
-4.29 %
Jan 1, 2027 (e)
66.13 %
7.97 %
2.31 %
Jan 1, 2028 (e)
66.13 %
7.97 %
4.77 %

Indoco Remedies Stock Revenue, EBIT, Earnings per Share

The Indoco Remedies earnings per share therefore indicates how much revenue Indoco Remedies has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
134.95 INR
16.46 INR
10.11 INR
Jan 1, 2022
167.48 INR
27.24 INR
16.83 INR
Jan 1, 2023
180.87 INR
23.52 INR
15.42 INR
Jan 1, 2024
196.97 INR
16.62 INR
10.67 INR
Jan 1, 2025
180.59 INR
-1.50 INR
-8.00 INR
Jan 1, 2026 (e)
190.77 INR
15.20 INR
-8.18 INR
Jan 1, 2027 (e)
227.92 INR
18.16 INR
5.28 INR
Jan 1, 2028 (e)
262.06 INR
20.88 INR
12.50 INR

Indoco Remedies business model & stock analysis

Indoco Remedies Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Indoco Remedies historical P/E ratio, EBIT multiple, and P/S ratio

Indoco Remedies annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Indoco Remedies shares outstanding

The number of shares of Indoco Remedies was 92.19 M in 2025. This indicates how many shares Indoco Remedies is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
92.00 M Stocks
Jan 1, 2022
92.00 M Stocks
Jan 1, 2023
92.26 M Stocks
Jan 1, 2024
92.26 M Stocks
Jan 1, 2025
92.19 M Stocks
Jan 1, 2026 (e)
92.19 M Stocks
Jan 1, 2027 (e)
92.19 M Stocks
Jan 1, 2028 (e)
92.19 M Stocks

Indoco Remedies Dividend History

21 years of dividend payments

YearAnnual DividendYoY ChangePayments
20250.20INR↓ 86.7%1×
Sep 4, 20250.20INR↓ 86.7%1/1
20241.50INR↓ 33.3%1×
20232.25INR↑ 50.0%1×
20221.50INR 0.0%1×
20211.50INR↑ 400.0%1×
20200.30INR 0.0%1×
20190.30INR↓ 70.0%1×
20181.00INR↓ 37.5%1×
20171.60INR↑ 0.0%1×
20161.60INR↓ 0.0%2×

Indoco Remedies dividend history and estimates

In 2025, Indoco Remedies paid a dividend amounting to 0.20 INR. Dividend means that Indoco Remedies distributes a portion of its profits to its owners.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2021
1.50 INR
0.00 INR
Jan 1, 2022
1.50 INR
0.00 INR
Jan 1, 2023
2.25 INR
0.00 INR
Jan 1, 2024
1.50 INR
0.00 INR
Jan 1, 2025
0.20 INR
0.00 INR
Jan 1, 2026
0.20 INR
0.00 INR
Jan 1, 2027 (e)
0.00 INR
0.20 INR
Jan 1, 2028 (e)
0.00 INR
0.20 INR

Indoco Remedies dividend payout ratio

In 2025, Indoco Remedies had a payout ratio of -2.50%. The payout ratio indicates the percentage of the company's profits that Indoco Remedies distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2021
14.85 %
Jan 1, 2022
8.92 %
Jan 1, 2023
14.59 %
Jan 1, 2024
14.06 %
Jan 1, 2025
-2.50 %
Jan 1, 2026 (e)
12.52 %
Jan 1, 2027 (e)
3.79 %
Jan 1, 2028 (e)
1.60 %

Current Indoco Remedies forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
10.00 %
Buy
11.11 % (1)
Hold
44.44 % (4)
Sell
44.44 % (4)
12M Price Target
261.63
Last Price
219.49
Currency
INR
12M Return Potential
19.20 %
LTM Return
0 %

Indoco Remedies Earnings Estimates & Surprises

DateEPS estimateEPS ActualRevenue EstimatePrice reactionQuarterly report
5/21/20244.85INR-4.77 BINR-2024 Q4
1/22/20244.29INR-4.42 BINR-2024 Q3

EESG©

Eulerpool ESG Scorecard© for the Indoco Remedies stock

65/100
43
Environment
83
Social
69
Governance
E

Environment

20
Scope 1 - Direct Emissions14,786.81
Scope 2 - Indirect emissions from purchased energy36,554.03
Scope 3 - Indirect emissions within the value chain—
Total CO₂ emissions51,340.84
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees8.248
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Indoco Remedies shareholder structure

% Name
6.16585%
Panandikar (Aditi Milind)
Panandikar (Aditi Milind)
5.69116%
Kare (Mdhura Suresh)
Kare (Mdhura Suresh)
0.49904%
Dimensional Fund Advisors, L.P.
Dimensional Fund Advisors, L.P.
0.09621%
Mellon Investments Corporation
Mellon Investments Corporation
0.05170%
Dimensional Fund Advisors, Ltd.
Dimensional Fund Advisors, Ltd.
0.01629%
American Century Investment Management, Inc.
American Century Investment Management, Inc.

Indoco Remedies Beneficial Ownership Filings (SEC 13D/G)

Free Float
38.9%
Float Shares
-
Shares Outstanding
-

Indoco Remedies Executives and Management Board

10 members · avg. age 62 · 20 % women

AP

Ms. Aditi Panandikar (54)

Chief Executive Officer, Managing Director, Executive Director · since 2004

85.42 M INR

Management

SB

Mr. Sundeep Bambolkar (63)

Joint Managing Director, Executive Director · since 2004

75.54 M INR
PG

Mr. Pramod Ghorpade

Chief Financial Officer

17.38 M INR
RH

Mr. Ramanathan Hariharan

Compliance Officer, Company Secretary, Head - Legal

5.48 M INR

Board of Directors

SK

Mr. Suresh Kare

Non-Executive Non-Independent Chairman of the Board · since 2023

9.89 M INR
VK

Dr. Vasudha Kamat (71)

Independent Non-Executive Director

500,000.00 INR
AG

Mr. Abhijit Gore (58)

Independent Non-Executive Director

460,000.00 INR
AN

Dr. Anand Nadkarni (65)

Non-Executive Non-Independent Director

360,000.00 INR
AM

Mr. Ajay Mulgaokar

Additional Non-Executive Independent Director

–
SS

Mr. Satish Shenoy

Additional Non-Executive Independent Director

–

Frequently asked questions about Indoco Remedies

Analysts currently set an average price target of 264.44 INR for the Indoco Remedies stock (median: 261.63 INR), implying +20.5 % versus the latest price. The consensus is based on 9 analyst ratings.

Indoco Remedies Analyst Price Targets 2026

9 analysts currently rate the Indoco Remedies stock: 1 recommend buying, 4 holding and 4 selling. For 2026, analysts expect Indoco Remedies to generate revenue of 17.59 B INR and earnings per share of -8.18 INR.

Indoco Remedies Analyst Price Targets 2026

Converted at the current exchange rate, the Indoco Remedies share trades at 2.00 EUR (219.49 INR).

No history available for Indoco Remedies.

The expected revenue of Indoco Remedies is 17.59 B INR. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Indoco Remedies is -753.69 M INR. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Indoco Remedies is currently -26.85. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Indoco Remedies stock.

The price-to-sales ratio (P/S) of Indoco Remedies is currently 1.15. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Indoco Remedies stock.

The Eulerpool Quality Score for Indoco Remedies is 2/10.

The ISIN of Indoco Remedies is INE873D01024. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Indoco Remedies is INDOCO.NS. The ticker symbol is used to trade Indoco Remedies shares on the stock exchange.

Over the past 12 months, Indoco Remedies paid a dividend of 0.20 INR . This corresponds to a dividend yield of about 0.09 %. For the coming 12 months, Indoco Remedies is expected to pay a dividend of 0.20 INR.

The current dividend yield of Indoco Remedies is 0.09 %.

Indoco Remedies pays a dividend, distributed in the months of , , , .

Indoco Remedies paid dividends every year for the past 21 years.

For the upcoming 12 months, dividends amounting to 0.20 INR are expected. This corresponds to a dividend yield of 0.09 %.

Indoco Remedies is assigned to the 'Health' sector.

To receive the latest dividend of Indoco Remedies from amounting to 0.2 INR, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

In the year 2025, Indoco Remedies distributed 2.25 INR as dividends.

The dividends of Indoco Remedies are distributed in INR.

All fundamentals and in-depth analysis of Indoco Remedies

Our stock analysis for Indoco Remedies stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Indoco Remedies. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Indoco Remedies Stock
Indoco Remedies Revenue→
Indoco Remedies Stock
Indoco Remedies Net Income→
Indoco Remedies Stock
Indoco Remedies P/E→
Indoco Remedies Stock
Indoco Remedies P/S→
Indoco Remedies Stock
Indoco Remedies EBIT→
Indoco Remedies Stock
Indoco Remedies Dividend→
Indoco Remedies Stock
Indoco Remedies Directors Dealings→
Indoco Remedies Stock
Indoco Remedies Stocks→
Indoco Remedies Stock
Indoco Remedies Market capitalization→
Indoco Remedies Stock
Indoco Remedies Debt→
Indoco Remedies Stock
Indoco Remedies Liabilities→
Indoco Remedies Stock
Indoco Remedies Equity→
Indoco Remedies Stock
Indoco Remedies AAQS→
Indoco Remedies Stock
Indoco Remedies Employees→
Indoco Remedies Stock
Indoco Remedies ROE→
Indoco Remedies Stock
Indoco Remedies ROA→
Indoco Remedies Stock
Indoco Remedies ROCE→
Indoco Remedies Stock
Indoco Remedies News→
Indoco Remedies Stock
Indoco Remedies Analyst Price Targets→

Health Stocks

Indofarma Tbk PTIndivior PharmaceuticalsIndraprastha Medical CorporationIndaptus TherapeuticsInfant Bacterial TherapeuticsIND Swift LaboratoriesInfinitt Healthcare CoIncyteInfinity PharmaceuticalsIncannex HealthcareInfinium PharmachemInBody CoAll Stocks A–Z →